Dapagliflozin in Physical Exercise in Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

April 26, 2023

Study Completion Date

May 10, 2023

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Forxiga 10mg

Dapagliflozin 10mg per 24 hours, oral, for 7 consecutive days

DRUG

Placebo

Placebo 1 tablet per 24 hours, oral, for 7 consecutive days

Trial Locations (1)

3010

Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT04049110 - Dapagliflozin in Physical Exercise in Type 1 Diabetes | Biotech Hunter | Biotech Hunter